Abstract Details

Title Very Mild Stroke Patients Significantly Benefit from the Use of Intravenous Tissue Plasminogen Activator without Any Increase of Hemorrhagic Conversion

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 093

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Bahareh Hassanzadeh, MD (Orlando Health)	Dr. Hassanzadeh has nothing to disclose.
Fumio Kanda, MD, PhD, FAAN (Kusunoki Neurology Clinic)	No disclosure on file
Vahid Tohidi, MD, PhD	Dr. Tohidi has nothing to disclose.
	No disclosure on file
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Islam M. Tafish, MD (tafish neuroscience)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��